This Week’s -10.29% Loss In Akebia Therapeutics Inc. (NASDAQ: AKBA) Taught Us Something New
Akebia Therapeutics Inc. (NASDAQ:AKBA)’s traded shares stood at 60.76 million during the last session, with the company’s beta value hitting 0.82. At the close of